Month: November 2023

Medical Device

Breakthrough Heart Surgery and Innovative Device Rescue Motorcyclist After Crash

Published November 29, 2023 Alfred Peterson’s routine motorcycle ride took a terrifying turn this spring when he collided with a vehicle, resulting in multiple fractures and life-threatening damage to his aorta. Quickly immobilized and placed in a medically-induced coma, Peterson’s situation demanded swift medical intervention. The medical team, led by Dr. Nicolas Zea from Cardiothoracic and Vascular Surgeons, faced the urgent need to address the … Continue reading Breakthrough Heart Surgery and Innovative Device Rescue Motorcyclist After Crash

Ann Poorboy
Lawsuits, Pharmaceuticals

Virginia Localities Take on Pharmaceutical Giants in Lawsuits Over Soaring Insulin Costs

The lawsuits filed by Virginia localities against insulin manufacturers and PBMs mark a significant step in the ongoing legal battles over rising drug prices. As the legal proceedings unfold, the outcomes may have far-reaching implications for the pharmaceutical industry and the broader healthcare landscape in the United States. The focus on alleged collusion and artificial price hikes brings attention to the complex dynamics between drug manufacturers, pharmacy benefit managers, and the impact on patients relying on life-saving medications. Continue reading Virginia Localities Take on Pharmaceutical Giants in Lawsuits Over Soaring Insulin Costs

Ann Poorboy
Brand Marketing, Pharmaceuticals

“Reckitt’s ‘Flip the Script’ Initiative: Transforming Antibiotic Culture and Promoting Respiratory Health”

In an era where health consciousness is paramount, Reckitt, a leading hygiene, health, and nutrition company renowned for household brands like Mucinex, Delsym, and Lysol, is spearheading a pioneering initiative known as the ‘Flip the Script’ campaign. This ambitious project is reshaping the narrative around antibiotic usage for cold and flu symptoms by partnering with urgent and primary care centers. The aim is not only to educate consumers about the risks of antibiotic misuse but also to position over-the-counter (OTC) solutions, particularly Reckitt’s Mucinex products, as optimal alternatives. Continue reading “Reckitt’s ‘Flip the Script’ Initiative: Transforming Antibiotic Culture and Promoting Respiratory Health”

Ann Poorboy
FDA, Pharmaceuticals

Advancing Pharmaceutical Traceability: FDA Holds Crucial Stakeholders’ Engagement

DSCSA directs the FDA to establish national licensure standards for wholesale distributors and third-party logistics providers, reinforcing the importance of regulatory measures to ensure the safety and security of the drug supply chain. This comprehensive approach aligns with global efforts to fortify pharmaceutical traceability and safeguard public health. Continue reading Advancing Pharmaceutical Traceability: FDA Holds Crucial Stakeholders’ Engagement

Ann Poorboy
Pharmaceuticals

Glenmark Pharma Surges Over 3% Amidst Optimistic Revenue Growth Forecast in FY24

Published November 15, 2023 In a recent announcement, Glenmark Pharmaceuticals witnessed a surge of more than 3% in its share value on Wednesday’s trading session. This positive upswing follows the company’s optimistic forecast for double-digit revenue growth in the financial year 2023–24. During an earnings conference call, the pharmaceutical giant unveiled its ambitious plan, anticipating a consolidated revenue growth of 10–11% for the upcoming fiscal … Continue reading Glenmark Pharma Surges Over 3% Amidst Optimistic Revenue Growth Forecast in FY24

Ann Poorboy
Pharmaceuticals

Medical Device Stocks Get Boost Amidst Positive Findings on Novo Nordisk’s Wegovy

Published November 14, 2023 Investors in U.S. medical device makers experienced a surge on Monday, fueled by optimistic sentiments surrounding the cardiac benefits associated with Novo Nordisk’s weight-loss drug, Wegovy. The impact on the beleaguered sector was perceived as less severe than initially feared, prompting a rebound in shares. The comprehensive results unveiled at a major medical meeting on Saturday bolstered analysts’ confidence in the … Continue reading Medical Device Stocks Get Boost Amidst Positive Findings on Novo Nordisk’s Wegovy

Ann Poorboy
Drug Delivery

Revolutionizing Healthcare: Global Pharmaceutical Drug Delivery Industry Set to Surge to US$3.5 Trillion by 2033

The pharmaceutical drug delivery market is on the brink of an unprecedented surge, with a projected Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period, according to Future Market Insights (FMI). In 2023, the industry stands at a remarkable US$1.9 trillion and is expected to reach an astounding US$3.5 trillion by 2033. This exceptional growth is fueled by a surge in demand for pharmaceutical medication delivery systems, driven by an increase in deaths among the elderly and cancer patients. Continue reading Revolutionizing Healthcare: Global Pharmaceutical Drug Delivery Industry Set to Surge to US$3.5 Trillion by 2033

Ann Poorboy
Pharmaceuticals

October 2023: AbbVie Leads the Charge as Top Drug Ad Spending Soars to $221 Million

AbbVie’s dominance in pharmaceutical advertising continued in October 2023, with Skyrizi leading the pack. The substantial increase in advertising spending across the top 10 drug ads reflects the industry’s commitment to promoting innovative treatments and reaching a broader audience. As the pharmaceutical landscape evolves, advertising expenditures remain a crucial factor in driving consumer awareness and engagement. Continue reading October 2023: AbbVie Leads the Charge as Top Drug Ad Spending Soars to $221 Million

Ann Poorboy
Pharmaceuticals

Eli Lilly’s Aggressive Expansion Plans Amid Mounjaro’s Soaring Demand

This expansion drive is crucial, as Mounjaro’s supply challenges coincide with the potential FDA approval of the drug, also known as tirzeptide, for weight loss treatment. Lilly has submitted applications for the weight management indication to both the FDA and the European Medicines Agency. The exact regulatory timeline remains unclear. Continue reading Eli Lilly’s Aggressive Expansion Plans Amid Mounjaro’s Soaring Demand

Ann Poorboy